Your browser doesn't support javascript.
loading
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.
Symonds, Lynn; Jenkins, Isaac; Linden, Hannah M; Kurland, Brenda; Gralow, Julie R; Gadi, Vijayakrishna V K; Ellis, Georgiana K; Wu, Qian; Rodler, Eve; Chalasani, Pavani; Chai, Xiaoyu; Riedel, Jinny; Stopeck, Alison; Brown-Glaberman, Ursa; Specht, Jennifer M.
Affiliation
  • Symonds L; Medical Oncology, University of Washington, Seattle, WA.
  • Jenkins I; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Linden HM; Medical Oncology, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Kurland B; eResearch Technologies, Inc., Pittsburgh, PA.
  • Gralow JR; Medical Oncology, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Gadi VVK; Medical Oncology, University of Illinois Cancer Center, Chicago, IL.
  • Ellis GK; Medical Oncology, University of Washington, Seattle, WA.
  • Wu Q; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Rodler E; Hematology and Oncology, University of California Davis, Sacramento, CA.
  • Chalasani P; Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ.
  • Chai X; Microsoft, Redmond, WA.
  • Riedel J; Clinical Cancer Genetics, Duke Cancer Institute, Durham, NC.
  • Scca Network Investigators; Seattle Cancer Care Alliance Network, Seattle, WA.
  • Stopeck A; Hematology and Oncology, Stony Brook University, Stony Brook, NY.
  • Brown-Glaberman U; Hematology and Oncology, University of New Mexico, Albuquerque, NM.
  • Specht JM; Medical Oncology, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Electronic address: jspecht@uw.edu.
Clin Breast Cancer ; 22(1): 32-42, 2022 01.
Article in En | MEDLINE | ID: mdl-34158245
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Granulocyte Colony-Stimulating Factor / Neoadjuvant Therapy / Inflammatory Breast Neoplasms / Sunitinib Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Granulocyte Colony-Stimulating Factor / Neoadjuvant Therapy / Inflammatory Breast Neoplasms / Sunitinib Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: